Cui-cui Li

发表

Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.

Li Li, Lei Wang, Q. You, 2018, European journal of medicinal chemistry.

3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation

Li Li, Lei Wang, Q. You, 2018, Oxidative medicine and cellular longevity.

Corrigendum to “3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation”

Li Li, Lei Wang, Q. You, 2018, Oxidative medicine and cellular longevity.

Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRASG12C.

Q. You, Bin Di, Li-li Xu, 2019, European journal of medicinal chemistry.

Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.

Bin Di, Li-li Xu, Cui-cui Li, 2020, Journal of autoimmunity.

Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.

Q. You, Weikang Tao, Ren Ren, 2022, Journal of medicinal chemistry.

5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.

Q. You, Bin Di, Zhengyu Jiang, 2019, Free radical biology & medicine.

Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.

Q. You, Bin Di, Cheng Jiang, 2020, Journal of medicinal chemistry.

Apoptosis-inducing activity of synthetic hydrocarbon-stapled peptides in H358 cancer cells expressing KRASG12C

Q. You, Bin Di, Li-li Xu, 2021, Acta pharmaceutica Sinica. B.